Raymond James & Associates’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-12,900
| Closed | -$33K | – | 3291 |
|
|
2017
Q1 | $33K | Buy |
12,900
+2,000
| +18% | +$5.12K | ﹤0.01% | 3088 |
|
|
2016
Q4 | $28K | Buy |
+10,900
| New | +$28K | ﹤0.01% | 3044 |
|
|
2015
Q1 | – | Sell |
-33,791
| Closed | -$213K | – | 2420 |
|
|
2014
Q4 | $213K | Sell |
33,791
-12,721
| -27% | -$80.2K | ﹤0.01% | 2197 |
|
|
2014
Q3 | $283K | Buy |
+46,512
| New | +$283K | ﹤0.01% | 2050 |
|
|
2014
Q2 | – | Sell |
-20,317
| Closed | -$484K | – | 2237 |
|
|
2014
Q1 | $484K | Buy |
+20,317
| New | +$484K | ﹤0.01% | 1798 |
|